Peripheral Blood Stem Cell TransplantationTransplantation, AutologousHematopoietic Stem Cell TransplantationHematopoietic Stem Cell MobilizationTransplantation ConditioningTransplantation, HomologousGranulocyte Colony-Stimulating FactorMelphalanLeukapheresisAntigens, CD34Combined Modality TherapyBlood Component RemovalHematologic NeoplasmsStem Cell TransplantationCyclophosphamideMultiple MyelomaAntineoplastic Combined Chemotherapy ProtocolsGraft vs Host DiseaseMyeloablative AgonistsBusulfanTreatment OutcomeGraft SurvivalBone Marrow TransplantationLymphoma, Non-HodgkinHematopoietic Stem CellsEtoposideThiotepaAntineoplastic Agents, AlkylatingRemission InductionRecurrenceCarmustineCytophagocytosisIfosfamideSalvage TherapyVincristineAmyloidosisHematopoiesisCytarabineStem CellsHodgkin DiseaseDisease-Free SurvivalGranulocytesCord Blood Stem Cell TransplantationTissue DonorsTransplantation ChimeraRetrospective StudiesNeoplasmsSurvival RateWhole-Body IrradiationTime FactorsSurvival AnalysisInfectionLymphoma, T-CellDoxorubicinHistocompatibilityImmunosuppressive AgentsPlatelet CountPOEMS SyndromeHistocompatibility TestingPrednisoneCarboplatinLeukemia, Myeloid, AcuteTransplantation, IsogeneicDexamethasoneRecombinant ProteinsVidarabineFollow-Up StudiesLeukemiaBlood Cell CountBone Marrow PurgingCytomegalovirus InfectionsBlood Transfusion, AutologousAntineoplastic AgentsProspective StudiesBlood CellsLymphomaFatal OutcomeGraft vs Leukemia EffectFeasibility StudiesMyelodysplastic SyndromesImmunophenotypingAnemia, AplasticKidney TransplantationT-LymphocytesLeukemia, Myelogenous, Chronic, BCR-ABL PositiveLymphocyte DepletionCyclosporineBone MarrowLiver TransplantationLeukocytes, MononuclearOpportunistic InfectionsHLA AntigensImmunosuppressionHematologic DiseasesPrognosisPrecursor Cell Lymphoblastic Leukemia-LymphomaHistiocytosis, Non-Langerhans-CellLivedo ReticularisBlood DonorsCell Separation